51 related articles for article (PubMed ID: 22498114)
21. 18F-FDG PET/CT for staging of penile cancer.
Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
[TBL] [Abstract][Full Text] [Related]
22. Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning.
Brocken P; Kiers BA; Looijen-Salamon MG; Dekhuijzen PN; Smits-van der Graaf C; Peters-Bax L; de Geus-Oei LF; van der Heijden HF
Lung Cancer; 2012 Mar; 75(3):336-41. PubMed ID: 21943652
[TBL] [Abstract][Full Text] [Related]
23. Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer.
Laroche C; Fairbairn I; Moss H; Pepke-Zaba J; Sharples L; Flower C; Coulden R
Thorax; 2000 May; 55(5):359-63. PubMed ID: 10770815
[TBL] [Abstract][Full Text] [Related]
24. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
[TBL] [Abstract][Full Text] [Related]
25. Reasons for prolonged time for diagnostic workup for stage I-II lung cancer and estimated effect of applying an optimized pathway for diagnostic procedures.
Stokstad T; Sørhaug S; Amundsen T; Grønberg BH
BMC Health Serv Res; 2019 Sep; 19(1):679. PubMed ID: 31533705
[TBL] [Abstract][Full Text] [Related]
26. A Structured Program Maximizes Benefit of Lung Cancer Screening in an Area of Endemic Histoplasmosis.
Miller JA; Tatakis A; Van Haren RM; Kapur S; Pathrose P; Hemingway M; Starnes SL
Ann Thorac Surg; 2022 Jul; 114(1):241-247. PubMed ID: 34339671
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic evaluation for interventional bronchoscopists and radiologists in lung cancer practice.
Lau WF; Ware R; Herth FJ
Respirology; 2015 Jul; 20(5):705-14. PubMed ID: 25823583
[TBL] [Abstract][Full Text] [Related]
28. A Patient-Centered Model of Fast-Track Lung Cancer Diagnosis.
Pradere P; Caramella C; Salem FB; Florea V; Crutu A; Hanna A; Mabille L; Kim YW; De Montpreville V; Feuillet S; Naltet C; Planchard D; Blanc E; Fadel E; Pavec JL; Mercier O
Clin Lung Cancer; 2023 Jul; 24(5):453-458. PubMed ID: 37030992
[TBL] [Abstract][Full Text] [Related]
29. New trends in diagnostic investigations in poisoned patients.
Drug Discov Today Technol; 2007; 4(3-4):e89-e108. PubMed ID: 24139381
[No Abstract] [Full Text] [Related]
30. Diagnostic investigations in family practice.
Strasser R
Can Fam Physician; 1989 Oct; 35():1975-80. PubMed ID: 21249072
[No Abstract] [Full Text] [Related]
31. Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study.
Slavova-Azmanova NS; Lizama C; Johnson CE; Ludewick HP; Lester L; Karunarathne S; Phillips M
BMC Cancer; 2016 Jan; 16():44. PubMed ID: 26822160
[TBL] [Abstract][Full Text] [Related]
32. Using the CT features to differentiate invasive pulmonary adenocarcinoma from pre-invasive lesion appearing as pure or mixed ground-glass nodules.
Liang J; Xu XQ; Xu H; Yuan M; Zhang W; Shi ZF; Yu TF
Br J Radiol; 2015 Sep; 88(1053):20140811. PubMed ID: 26090823
[TBL] [Abstract][Full Text] [Related]
33. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
34. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
[TBL] [Abstract][Full Text] [Related]
36. Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.
Buchbender C; Herbrik M; Treffert J; Forsting M; Bockisch A; Antoch G; Heusner TA
Expert Rev Med Devices; 2012 May; 9(3):241-7. PubMed ID: 22702254
[TBL] [Abstract][Full Text] [Related]
37. A diagnostic program for patients suspected of having lung cancer.
Stigt JA; Uil SM; Oostdijk AH; Boers JE; van den Berg JW; Groen HJ
Clin Lung Cancer; 2012 Nov; 13(6):475-81. PubMed ID: 22498114
[TBL] [Abstract][Full Text] [Related]
38. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
